Transaction #33586 · Form 4 · 0001045463-26-000021
PROTHENA CORP PUBLIC LTD CO · Purchase · Ordinary Shares, par value $0.01 per share
PROTHENA CORP PUBLIC LTD CO · Transacted October 14, 2026 · Filed October 15, 2026
What does this filing report?
An SEC Form 4 filing for PROTHENA CORP PUBLIC LTD CO records a purchase involving Ordinary Shares, par value $0.01 per share on October 14, 2026. The reported quantity was 10,000. The filing date is October 15, 2026. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- PROTHENA CORP PUBLIC LTD CO
- Company CIK
- 0001559053
- Security type
- Non-derivative
- Acquisition type
- Purchase · Code P
- Quantity acquired
- 10,000
- Reported price
- 8.4569 · See footnotes
- Reference value
- 84,569
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 1,037,000
- Ownership description
- Not reported
- SEC acceptance time
- Oct 15, 2026, 4:21 PM EDT
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- SCULLY WILLIAM P ↗
10% owner
CIK 0001045463
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Filing footnotes & remarks
- F1
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.2547 to $8.4616, inclusive. The reporting person undertakes to provide to Prothena Corp Public Ltd Co, any security holder of Prothena Corp Public Ltd Co, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
- F2
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.4000 to $8.5600, inclusive.
- F3
- The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.